Pathway Study MAD
Autoimmune diseases are diseases in which the body’s own immune system attacks one or more organ systems in the body resulting in injury to the body and illness.The purpose of this study is to test a potential new treatment for autoimmune diseases.
For this initial stage of research, we require healthy participants to assess to safety and tolerability of the medication, how it is absorbed in the bloodstream, and whether you develop antibodies to the drug. If this study is successful, in later stages the medication will be tested with people who have autoimmune conditions such as cold agglutinin disease (CAD), warm autoimmune hemolytic anemia (wAIHA), and eye conditions such as glaucoma.
The trial has been approved by an independent ethics committee and participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!